Clinical Trials Browser

Phase 2 × INDUSTRY × treosulfan × Clear all

NCT02333058 2020-05-04

Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies

Phase 2 Completed

Myelodysplastic Syndromes

NCT01063660 2010-02-05

Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01062490 2010-02-04

Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes